4.8 Article

Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity

Journal

SCIENCE
Volume 332, Issue 6025, Pages 65-68

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.1200439

Keywords

-

Funding

  1. INSERM
  2. University Paris Descartes
  3. Rockefeller University
  4. Rockefeller University CTSA [5UL1RR024143-04]
  5. St. Giles Foundation
  6. Candidoser association

Ask authors/readers for more resources

Chronic mucocutaneous candidiasis disease (CMCD) is characterized by recurrent or persistent infections of the skin, nails, and oral and genital mucosae caused by Candida albicans and, to a lesser extent, Staphylococcus aureus, in patients with no other infectious or autoimmune manifestations. We report two genetic etiologies of CMCD: autosomal recessive deficiency in the cytokine receptor, interleukin-17 receptor A (IL-17RA), and autosomal dominant deficiency of the cytokine interleukin-17F (IL-17F). IL-17RA deficiency is complete, abolishing cellular responses to IL-17A and IL-17F homo-and heterodimers. By contrast, IL-17F deficiency is partial, with mutant IL-17F-containing homo-and heterodimers displaying impaired, but not abolished, activity. These experiments of nature indicate that human IL-17A and IL-17F are essential for mucocutaneous immunity against C. albicans, but otherwise largely redundant.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available